Johnson & Johnson Vision Care

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Johnson & Johnson Vision Care sits in the top decile of US sponsors by registered trial count (#197 of 15,742 sponsors by registered trial count).

142 total trials 1 currently recruiting 139 completed early-phase tilt top decile by trial count

Johnson & Johnson Vision Care: 142 sponsored US clinical trials, 1 recruiting.

Johnson & Johnson Vision Care sponsors 142 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 139 completed. 2 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Visual Acuity, with 19 trials.

Top-decile sponsor footprint

Johnson & Johnson Vision Care ranks in the top decile of sponsors by registered trial count (#197 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

B 86/100

139 of 141 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (98.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

142 total, page 1 of 3

RECRUITING NA

Evaluation of Effect of Scatter on Visual Performance

NCT07443215

COMPLETED NA

Evaluation of Approved Contact Lenses

NCT07174596

COMPLETED NA

Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses

NCT07076160

COMPLETED NA

Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process

NCT06967129

COMPLETED NA

Clinical Evaluation of Two Cosmetic Contact Lenses

NCT06864858

COMPLETED NA

Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of Wear

NCT06749496

COMPLETED NA

Evaluation of the Clinical Performance of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses

NCT06377488

COMPLETED NA

Evaluation of Acuvue Oasys 1-Day Contact Lenses in New Wearers

NCT06333613

COMPLETED

Clinical Investigation on Assessing the Repeatability and Reproducibility of Central and Peripheral Refractive Error

NCT06209476

COMPLETED NA

Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of Wear

NCT06161012

COMPLETED

Characterization of the Central and Peripheral Wavefront Aberration Profile in Pediatric Myopic Subjects

NCT06075576

COMPLETED NA

Characterizing the Intraocular Scattering at Different Wavelengths

NCT05602623

COMPLETED Phase 2

Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of Investigational Lubricating Eye Drops

NCT05814367

COMPLETED NA

Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking Chromophore

NCT05778786

COMPLETED Phase 2

Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients

NCT05661851

COMPLETED NA

Evaluation of ACUVUE® OASYS 1-Day for Astigmatism Contact Lenses With Alternative Lidstock

NCT05713552

COMPLETED NA

The Effects of Contact Lenses With UV/HEV-Filter on Visual Function

NCT05601544

COMPLETED NA

Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study

NCT05582304

COMPLETED NA

Clinical Evaluation of Delefilcon A and Verofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of Wear

NCT05502289

COMPLETED NA

Feasibility Evaluation of Daily Disposable Toric Soft Contact Lenses Manufactured With an Alternative Hydration Process

NCT05427539

COMPLETED NA

Evaluation of Rotation With a Multifocal Toric Contact Lens

NCT05433571

COMPLETED NA

Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology to Evaluate Overall Visual Acuity.

NCT05361304

COMPLETED NA

Evaluation of Toric Soft Contact Lenses Containing a Chromophore to Block High-Energy Visible Light

NCT05344560

COMPLETED NA

Clinical Evaluation of Two Daily Disposable Toric Soft Contact Lenses Over One Week of Wear

NCT05291936

COMPLETED NA

Clinical Performance of Senofilcon A Investigational Lens

NCT05300763

COMPLETED NA

Comparison of a Silicone Hydrogel Daily Disposable Multifocal Contact Lens to a Marketed Product

NCT05258149

COMPLETED NA

Evaluation of Marketed Soft Contact Lenses

NCT05201807

COMPLETED NA

Evaluation of a Daily Disposable Silicone Hydrogel Multifocal Contact Lens in Myopes and Hyperopes

NCT05222880

COMPLETED

Visual Performance of Soft Contact Lenses With Myopia Control Optics

NCT05141448

COMPLETED NA

Evaluation of Multifocal Contact Lens Designs With and Without an HEV Blocker on Visual Function

NCT04995055

COMPLETED NA

Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product

NCT05101252

COMPLETED NA

Validation of Senofilcon A With New UV / HEV Filter

NCT05099380

COMPLETED NA

Clinical Evaluation of Spherical Soft Contact Lenses, Toric Soft Contact Lenses and Spectacles in Low Astigmats

NCT05056870

COMPLETED NA

Visual Performance of Senofilcon A With and Without a New UV/HEV-filter

NCT05021081

COMPLETED NA

Evaluation of Visual Acuity With a Reusable Toric Multifocal Contact Lens

NCT05000164

COMPLETED NA

Evaluation of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses

NCT04974697

COMPLETED NA

The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity Analyzer

NCT04811079

COMPLETED NA

Evaluation of Comfort for Two Marketed Daily Disposable Contact Lenses

NCT04968925

COMPLETED

Evaluating Visual Acuity and Initial Fit Performance of Two Soft Contact Lenses

NCT04954833

COMPLETED NA

Evaluation of Investigational Daily Disposable Multifocal Contact Lenses Produced With Different Manufacturing Processes in Myopes

NCT04889625

COMPLETED NA

Evaluation of Prototype Lenses With Experimental UV/HEV Blocker

NCT04885296

COMPLETED NA

Evaluation of Dryness in a Silicone Hydrogel Daily Disposable Contact Lens

NCT04849780

COMPLETED NA

Evaluation of Investigational Daily Disposable Multifocal Contact Lenses Produced With Different Manufacturing Processes

NCT04794751

COMPLETED NA

Evaluation of ACUVUE OASYS® 1-Day for Astigmatism Lenses Produced on a New Manufacturing Line

NCT04794270

COMPLETED NA

Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population; Part 2

NCT04615507

COMPLETED Phase 1

Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye Drop

NCT06131476

COMPLETED NA

Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Hyperopic Population

NCT04567186

COMPLETED NA

Clinical Evaluation of Daily Disposable Etafilcon A Cosmetic Contact Lenses

NCT04529109

COMPLETED NA

Clinical Evaluation of a Daily Wear Reusable Multifocal Optical Design in a Presbyopic Population

NCT04534517

COMPLETED NA

Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology

NCT04531241

Page 1 of 3 Next →

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 4
Phase 4 2

What is open in the Johnson & Johnson Vision Care pipeline

1 recruiting of 142 indexed (1% open); 139 completed (98%).

Phase mix: 2 late (III/IV) vs 7 early (I/II) (early-phase heavy).

Top condition: Visual Acuity (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Johnson & Johnson Vision Care: open-pipeline peers nationwide

Peers matched on 142 registered trials and 1% open enrollment, not the therapeutic-area sidebar.

Johnson & Johnson Vision Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 50100150200250300 0%5%10%15%20% Total trials Recruiting share Johnson & Johnson Vision CareCase Western Reserve UniversityEastern Cooperative Oncology GroupPurdue UniversityRadiation Therapy Oncology GroupMylan PharmaceuticalsGynecologic Oncology GroupShireAbbott Nutrition
Johnson & Johnson Vision Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Johnson & Johnson Vision Care sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 142 trials (± recruiting share)

Sponsors near 1% open enrollment (± trial volume)

What to do with this Johnson & Johnson Vision Care page

142 registered trials is a research-attention snapshot, not an endorsement of Johnson & Johnson Vision Care or any single study.

  • 1 of Johnson & Johnson Vision Care's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Visual Acuity is the condition Johnson & Johnson Vision Care studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Visual Acuity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Johnson & Johnson Vision Care pipeline card: 142 registered trials from official public datasets.Report a data error.